Gideon Morris Hirschfield

30PUBLICATIONS

173CO-AUTHORS

Radiation therapyGastroenterology and hepatologyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|May 12, 2026

Reply: Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

|Dec 01, 2025

Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial.

John M Vierling, Gideon M Hirschfield, Robert P Kustra

|Nov 18, 2025

Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract Cancers.

Xin Wang, Jaime Ivan Haro-Silerio, Felix E G Beaudry

|Sep 29, 2025

High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapy.

Guilherme G L Cançado, Bo Chen, Madeline Cameron

|Jun 13, 2025

Editorial: Patient Reported Outcomes Provide Insight Into Disease Severity for People Living With Primary Sclerosing Cholangitis.

Aisha Alawi, Gideon M Hirschfield

|Apr 30, 2025

Hepatobiliary complications in patients with sickle cell disease: A 30-year review of 1009 patients.

Maya Deeb, Kristel K Leung, Richard Ward

Pageof 5

Frequent Collaborators

Palak Trivedi

Cynthia Levy

Marlyn Mayo

Aliya Gulamhusein

John M Vierling

Christopher L Bowlus

Mamatha Bhat

Stephen D Ryder

Mark Swain

Douglas Thorburn

Frequent Collaborators

Palak Trivedi

Cynthia Levy

Marlyn Mayo

Aliya Gulamhusein